To contract out the conduct of a multi centre efficacy, safety and tolerability study of an intravenous immunoglobulin in adult subjects with primary immune deficiency. The study will potentially take place in the USA, UK and Israel.
Get our periodical newsletter about how sell more to the public sector and how to make the most of Tenderlake.